Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration

Bettina Mittendorfer, Dennis Gore, David Herndon, Robert R. Wolfe

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Muscle glutamine is severely depleted in critically ill patients (by ~50% to 80% of normal). Because muscle protein breakdown, and thus the release of glutamine from muscle protein, is enhanced in response to metabolic stress, the depletion of intramuscular glutamine could be due to its impaired synthesis or accelerated outward transport or both. Methods: To distinguish these possibilities, we measured skeletal muscle glutamine metabolism in five critically ill patients by means of primed, continuous infusions of 5-15N-glutamine and ring-2H5-phenylalanine and compared them to values we previously reported for healthy volunteers. Results: The intramuscular free glutamine concentration in patients was ~70% of that in healthy volunteers (5.8 ± 0.6 mmol/L intracellular free water vs 21.5 ± 2.8 mmol/L). Whole-body glutamine rate of appearance was 5.8 ± 1.0 μmol · kg- 1 body wt · min-1, and whole-body clearance was 19.3 ± 3.3 mL · kg-1 · min-1. Despite the low intramuscular glutamine concentration in the patients, the rate of unidirectional outward transport from skeletal muscle into venous blood (1.1. ± 0.2 μmol · 100 mL · leg-1 · min-1) was similar to that observed in healthy volunteers (1.6 ± 0.2 μmol · 100 mL · leg-1 · min-1); intramuscular synthesis was 2.7 ± 0.9 μmol · 100 mL · leg-1 · min-1 compared with a normal value of 0.6 ± 0.06 μmol · 100 mL · leg-1 · min-1. Net balance across the leg was normal. Conclusions: The depletion of intramuscular glutamine in critically ill patients is not due to an impairment of the rate of synthesis. In fact, accelerated glutamine production cannot maintain normal intramuscular glutamine levels because of accelerated outward transport.

Original languageEnglish (US)
Pages (from-to)243-252
Number of pages10
JournalJournal of Parenteral and Enteral Nutrition
Volume23
Issue number5
StatePublished - 1999

Fingerprint

Glutamine
Critical Illness
glutamine
synthesis
Leg
legs
volunteers
Healthy Volunteers
Muscle Proteins
muscle protein
skeletal muscle
Skeletal Muscle
Physiological Stress
Phenylalanine
phenylalanine
normal values
Reference Values
Muscles
muscles
metabolism

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration. / Mittendorfer, Bettina; Gore, Dennis; Herndon, David; Wolfe, Robert R.

In: Journal of Parenteral and Enteral Nutrition, Vol. 23, No. 5, 1999, p. 243-252.

Research output: Contribution to journalArticle

@article{f8b1a97229f84d30894ddb4c2e8bd25a,
title = "Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration",
abstract = "Background: Muscle glutamine is severely depleted in critically ill patients (by ~50{\%} to 80{\%} of normal). Because muscle protein breakdown, and thus the release of glutamine from muscle protein, is enhanced in response to metabolic stress, the depletion of intramuscular glutamine could be due to its impaired synthesis or accelerated outward transport or both. Methods: To distinguish these possibilities, we measured skeletal muscle glutamine metabolism in five critically ill patients by means of primed, continuous infusions of 5-15N-glutamine and ring-2H5-phenylalanine and compared them to values we previously reported for healthy volunteers. Results: The intramuscular free glutamine concentration in patients was ~70{\%} of that in healthy volunteers (5.8 ± 0.6 mmol/L intracellular free water vs 21.5 ± 2.8 mmol/L). Whole-body glutamine rate of appearance was 5.8 ± 1.0 μmol · kg- 1 body wt · min-1, and whole-body clearance was 19.3 ± 3.3 mL · kg-1 · min-1. Despite the low intramuscular glutamine concentration in the patients, the rate of unidirectional outward transport from skeletal muscle into venous blood (1.1. ± 0.2 μmol · 100 mL · leg-1 · min-1) was similar to that observed in healthy volunteers (1.6 ± 0.2 μmol · 100 mL · leg-1 · min-1); intramuscular synthesis was 2.7 ± 0.9 μmol · 100 mL · leg-1 · min-1 compared with a normal value of 0.6 ± 0.06 μmol · 100 mL · leg-1 · min-1. Net balance across the leg was normal. Conclusions: The depletion of intramuscular glutamine in critically ill patients is not due to an impairment of the rate of synthesis. In fact, accelerated glutamine production cannot maintain normal intramuscular glutamine levels because of accelerated outward transport.",
author = "Bettina Mittendorfer and Dennis Gore and David Herndon and Wolfe, {Robert R.}",
year = "1999",
language = "English (US)",
volume = "23",
pages = "243--252",
journal = "JPEN. Journal of parenteral and enteral nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration

AU - Mittendorfer, Bettina

AU - Gore, Dennis

AU - Herndon, David

AU - Wolfe, Robert R.

PY - 1999

Y1 - 1999

N2 - Background: Muscle glutamine is severely depleted in critically ill patients (by ~50% to 80% of normal). Because muscle protein breakdown, and thus the release of glutamine from muscle protein, is enhanced in response to metabolic stress, the depletion of intramuscular glutamine could be due to its impaired synthesis or accelerated outward transport or both. Methods: To distinguish these possibilities, we measured skeletal muscle glutamine metabolism in five critically ill patients by means of primed, continuous infusions of 5-15N-glutamine and ring-2H5-phenylalanine and compared them to values we previously reported for healthy volunteers. Results: The intramuscular free glutamine concentration in patients was ~70% of that in healthy volunteers (5.8 ± 0.6 mmol/L intracellular free water vs 21.5 ± 2.8 mmol/L). Whole-body glutamine rate of appearance was 5.8 ± 1.0 μmol · kg- 1 body wt · min-1, and whole-body clearance was 19.3 ± 3.3 mL · kg-1 · min-1. Despite the low intramuscular glutamine concentration in the patients, the rate of unidirectional outward transport from skeletal muscle into venous blood (1.1. ± 0.2 μmol · 100 mL · leg-1 · min-1) was similar to that observed in healthy volunteers (1.6 ± 0.2 μmol · 100 mL · leg-1 · min-1); intramuscular synthesis was 2.7 ± 0.9 μmol · 100 mL · leg-1 · min-1 compared with a normal value of 0.6 ± 0.06 μmol · 100 mL · leg-1 · min-1. Net balance across the leg was normal. Conclusions: The depletion of intramuscular glutamine in critically ill patients is not due to an impairment of the rate of synthesis. In fact, accelerated glutamine production cannot maintain normal intramuscular glutamine levels because of accelerated outward transport.

AB - Background: Muscle glutamine is severely depleted in critically ill patients (by ~50% to 80% of normal). Because muscle protein breakdown, and thus the release of glutamine from muscle protein, is enhanced in response to metabolic stress, the depletion of intramuscular glutamine could be due to its impaired synthesis or accelerated outward transport or both. Methods: To distinguish these possibilities, we measured skeletal muscle glutamine metabolism in five critically ill patients by means of primed, continuous infusions of 5-15N-glutamine and ring-2H5-phenylalanine and compared them to values we previously reported for healthy volunteers. Results: The intramuscular free glutamine concentration in patients was ~70% of that in healthy volunteers (5.8 ± 0.6 mmol/L intracellular free water vs 21.5 ± 2.8 mmol/L). Whole-body glutamine rate of appearance was 5.8 ± 1.0 μmol · kg- 1 body wt · min-1, and whole-body clearance was 19.3 ± 3.3 mL · kg-1 · min-1. Despite the low intramuscular glutamine concentration in the patients, the rate of unidirectional outward transport from skeletal muscle into venous blood (1.1. ± 0.2 μmol · 100 mL · leg-1 · min-1) was similar to that observed in healthy volunteers (1.6 ± 0.2 μmol · 100 mL · leg-1 · min-1); intramuscular synthesis was 2.7 ± 0.9 μmol · 100 mL · leg-1 · min-1 compared with a normal value of 0.6 ± 0.06 μmol · 100 mL · leg-1 · min-1. Net balance across the leg was normal. Conclusions: The depletion of intramuscular glutamine in critically ill patients is not due to an impairment of the rate of synthesis. In fact, accelerated glutamine production cannot maintain normal intramuscular glutamine levels because of accelerated outward transport.

UR - http://www.scopus.com/inward/record.url?scp=0033507705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033507705&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 243

EP - 252

JO - JPEN. Journal of parenteral and enteral nutrition

JF - JPEN. Journal of parenteral and enteral nutrition

SN - 0148-6071

IS - 5

ER -